Insider Trading Alert - WBMD, DATA And ANDE Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Aug. 27, 2014, 98 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $66.82 to $18,231,262.91.

Highlighted Stocks Traded by Insiders:

WebMD Health (WBMD) - FREE Research Report

Manning James V, who is Director at WebMD Health, sold 21,106 shares at $49.04 on Aug. 27, 2014. Following this transaction, the Director owned 132,248 shares meaning that the stake was reduced by 13.76% with the 21,106-share transaction.

The shares most recently traded at $48.07, down $0.97, or 2.01% since the insider transaction. Historical insider transactions for WebMD Health go as follows:

  • 4-Week # shares sold: 198,391
  • 12-Week # shares sold: 198,391
  • 24-Week # shares sold: 198,391

The average volume for WebMD Health has been 561,100 shares per day over the past 30 days. WebMD Health has a market cap of $1.9 billion and is part of the technology sector and computer software & services industry. Shares are up 21.77% year-to-date as of the close of trading on Wednesday.

WebMD Health Corp. provides health information services to consumers, physicians and other healthcare professionals, employers, and health plans through its public and private online portals, mobile platforms, and health-focused publications in the United States. The company has a P/E ratio of 73.0. Currently, there are 4 analysts who rate WebMD Health a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WBMD - FREE

TheStreet Quant Ratings rates WebMD Health as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, notable return on equity and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full WebMD Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Tableau Software (DATA) - FREE Research Report

Drant Ryan D, who is 10% Owner at Tableau Software, sold 10,000 shares at $61.94 on Aug. 27, 2014. Following this transaction, the 10% Owner owned 11,697 shares meaning that the stake was reduced by 46.09% with the 10,000-share transaction.

The shares most recently traded at $61.31, down $0.63, or 1.04% since the insider transaction. Historical insider transactions for Tableau Software go as follows:

  • 4-Week # shares sold: 17,000
  • 12-Week # shares sold: 17,000
  • 24-Week # shares sold: 126,000

The average volume for Tableau Software has been 1.3 million shares per day over the past 30 days. Tableau Software has a market cap of $2.6 billion and is part of the technology sector and computer software & services industry. Shares are down 9.63% year-to-date as of the close of trading on Wednesday.

Tableau Software, Inc. provides various business analytics software products in the United States, Canada, and internationally. The company has a P/E ratio of 409.9. Currently, there are 7 analysts who rate Tableau Software a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DATA - FREE

TheStreet Quant Ratings rates Tableau Software as a sell. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself, feeble growth in its earnings per share and unimpressive growth in net income. Get the full Tableau Software Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Andersons (ANDE) - FREE Research Report

Rex Anne G, who is VP & Corporate Controller at Andersons, sold 1,500 shares at $66.69 on Aug. 27, 2014. Following this transaction, the VP & Corporate Controller owned 13,659 shares meaning that the stake was reduced by 9.9% with the 1,500-share transaction.

The shares most recently traded at $66.90, up $0.21, or 0.31% since the insider transaction. Historical insider transactions for Andersons go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 5,662
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 8,662
  • 24-Week # shares bought: 2,965
  • 24-Week # shares sold: 8,662

The average volume for Andersons has been 295,000 shares per day over the past 30 days. Andersons has a market cap of $1.9 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 12.61% year-to-date as of the close of trading on Wednesday.

The Andersons, Inc. is engaged in the grain, ethanol, plant nutrient, railcar leasing, turf and cob products, and consumer retailing businesses. It operates in six segments: Grain, Ethanol, Rail, Plant Nutrient, Turf & Specialty, and Retail. The stock currently has a dividend yield of 0.66%. The company has a P/E ratio of 16.5. Currently, there are 4 analysts who rate Andersons a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ANDE - FREE

TheStreet Quant Ratings rates Andersons as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, attractive valuation levels and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Andersons Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Video: You Could Live in a Ritz-Carlton or St. Regis Home

Video: You Could Live in a Ritz-Carlton or St. Regis Home